These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3785687)

  • 1. [Effect of sera from patients with hepatolenticular degeneration treated with D-penicillamine on the development of Wilsonian gliopathy in vitro].
    Weinrauder H; Mossakowski MJ; Ganuszkina IV
    Neuropatol Pol; 1986; 24(2):169-81. PubMed ID: 3785687
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunomorphology of Wilsonian and hepatic gliopathy in vitro.
    Mossakowski MJ; Weinrauder H
    Neuropatol Pol; 1984; 22(2):161-78. PubMed ID: 6384819
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fibrinolytic activity in patients with hepatolenticular degeneration: the effect of penicillamine].
    Babić T; Relja M
    Lijec Vjesn; 1988 Dec; 110(12):420-2. PubMed ID: 3246941
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hepatolenticular degeneration treated by Cuprenil Polfa (d-penicillamine)].
    Hasik J; Kozal H
    Pol Tyg Lek; 1975 Aug 4-11; 30(31-32):1329-30. PubMed ID: 1161576
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanisms of pennicillamine and zinc in the treatment of Wilson's disease.
    Farinati F; Cardin R; Mestriner C; Sturniolo GC; Naccarato R
    Am J Gastroenterol; 1995 Dec; 90(12):2264-5. PubMed ID: 8540540
    [No Abstract]   [Full Text] [Related]  

  • 6. [On hepatolenticular degeneration (Wilson's disease). II. Treatment of 2 cases of Wilson's disease for 8 months with D-penicillamine].
    Germinario L; Campanella G; D'Addabbo A
    Acta Neurol (Napoli); 1971; 26(4):423-35. PubMed ID: 5132824
    [No Abstract]   [Full Text] [Related]  

  • 7. [Wilson's disease treated by penicillamine: favorable effect].
    Petit H
    Lille Med; 1968 Dec; 13(10):1132-4. PubMed ID: 5711646
    [No Abstract]   [Full Text] [Related]  

  • 8. D-penicillamine.
    Singh S; Kohli V
    Indian Pediatr; 1991 Jul; 28(7):779-85. PubMed ID: 1800352
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of D-penicillamine on hepatic gliopathy in tissue culture].
    Mossakowski MJ; Kraśnicka Z; Gajkowska B
    Neuropatol Pol; 1977; 15(1):57-74. PubMed ID: 840390
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hepatolemticular degeneration (Wison's disease): prolonged treatment with D-penicillamine in 3 cases].
    Balcells A; Cabrer B; Cano JF; Coll J; Ingelmo M; Vivancos J
    Rev Clin Esp; 1976 Oct; 143(2):157-64. PubMed ID: 1013453
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies of the hepatolenticular degeneration and results of its continuous therapy].
    Brailski C; Kolarski V; Krastev I
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):35-42. PubMed ID: 5501424
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experiences with long-term therapy of Wilson's disease].
    Schindler H
    Wien Z Inn Med; 1967; 48(12):465-9. PubMed ID: 5620587
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hepatolenticular degeneration, Wilson's disease. A characteristics case with remission under penicillamine therapy].
    Hansen J; Andersen OS
    Ugeskr Laeger; 1969 Jul; 131(31):1306-9. PubMed ID: 5824791
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cutis hyperelastica following prolonged administration of penicillamine in a patient with Wilson's disease].
    Charlebois G; Cadotte M; Barbeau A
    Union Med Can; 1972 May; 101(5):893-5. PubMed ID: 4666894
    [No Abstract]   [Full Text] [Related]  

  • 15. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
    D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
    Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
    [No Abstract]   [Full Text] [Related]  

  • 16. [Wilson's disease. Introduction to current problems (early diagnosis and therapy)].
    Wewalka F
    Wien Z Inn Med; 1967; 48(12):461-5. PubMed ID: 5620586
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of neurologic manifestations of Wilson's disease using penicillamine].
    Hartl J; Hauftová D
    Cesk Neurol; 1970 Mar; 33(2):89-93. PubMed ID: 5417217
    [No Abstract]   [Full Text] [Related]  

  • 18. Morphology and histochemistry of Wilsonian and hepatogenic gliopathy in tissue culture.
    Mossakowski MJ; Renkawek K; Kraśnicka Z; Smialek M; Pronaszko A
    Acta Neuropathol; 1970; 16(1):1-16. PubMed ID: 4247952
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuromuscular transmission and acetylcholine receptor antibodies in penicillamine-treated Wilson's disease patients.
    Anlar B; Kuruoğlu R; Varli K; Topçu M
    Muscle Nerve; 1996 May; 19(5):676-7. PubMed ID: 8618573
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hepatocerebral degeneration (Wilson's disease). Demonstration of the clinical picture and demonstration of own case].
    Rosenberger K
    Nervenarzt; 1973 Sep; 44(9):484-7. PubMed ID: 4750027
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.